All News Tissue Repair Ltd

Equities

TRP

AU0000180887

Market Closed - Australian S.E. Other stock markets 01:50:23 2024-05-10 EDT			5-day change	1st Jan Change
0.23 ^AUD	-2.13%		-6.12%	+4.55%

02-29	Tissue Repair Limited Announces Change of Company Secretary	CI
02-28	Tissue Repair Ltd Reports Earnings Results for the Half Year Ended December 31, 2023	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Tissue Repair Limited Announces Change of Company Secretary	02-29	CI
Tissue Repair Ltd Reports Earnings Results for the Half Year Ended December 31, 2023	02-28	CI
Tissue Repair Secures Third US Patent for Glucoprime Compound	12-18	MT
17,604,240 Options of Tissue Repair Ltd are subject to a Lock-Up Agreement Ending on 18-NOV-2023.	11-17	CI
13,684,488 Ordinary Shares of Tissue Repair Ltd are subject to a Lock-Up Agreement Ending on 18-NOV-2023.	11-17	CI
Tissue Repair Ltd Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-30	CI
Tissue Repair Limited Announces Company Secretary Changes	23-06-28	CI
Tissue Repair Secures US FDA Clearance for Phase Three Leg Ulcer Trial	23-05-29	MT
Tissue Repair Ltd Appoints Michael Silberberg as Director	23-05-02	CI
Tissue Repair Ltd Announces Board Resignations	23-04-26	CI
Tissue Repair Ltd Reports Earnings Results for the Half Year Ended December 31, 2022	23-02-22	CI
Tissue Repair to Test TR-987 Drug in 2023	22-09-29	MT
Tissue Repair Ltd Announces Change of Company Secretary	22-09-27	CI
Tissue Repair Limited Announces That It Has Received Responses to the Matters Raised in the Type C Meeting That the Company Submitted to the FDA on June 29, 2022	22-09-27	CI
Tissue Repair Secures Second US Patent for Use of Active Ingredient in Skin Conditions	22-09-05	MT
Tissue Repair Limited to Enter a Phase 3 Program in Venous Leg Ulcers	22-09-04	CI
BridgeBio Pharma Affiliate Phoenix Tissue Repair Announces Positive Results from Phase 2 Trial of PTR-01, a Protein Replacement Therapy for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB)	22-05-23	AQ
3,770,440 Ordinary Shares of Tissue Repair Ltd are subject to a Lock-Up Agreement Ending on 30-APR-2022.	22-04-29	CI
Australian Shares Fall Amid Global Selloff as Russia Continues Assault on Ukraine	22-03-04	MT
Tissue Repair Secures US Patent Approval for Wound Drug; Shares Sink 8%	22-03-03	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Tissue Repair Ltd

Equities

TRP

AU0000180887

All News

Filters